pfizer mrna based vaccine Search Results


lipid nanoparticle-based pfizer/biontech mrna covid-19 vaccines  (BioNTech)
90
BioNTech lipid nanoparticle-based pfizer/biontech mrna covid-19 vaccines
Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein <t>nanoparticles,</t> inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.
Lipid Nanoparticle Based Pfizer/Biontech Mrna Covid 19 Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+mrna+based+vaccine/pmc08730377-8-6-8?v=BioNTech
Average 90 stars, based on 1 article reviews
lipid nanoparticle-based pfizer/biontech mrna covid-19 vaccines - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
pfizer-biontech covid-19 lipid np mrna vaccines  (BioNTech)
90
BioNTech pfizer-biontech covid-19 lipid np mrna vaccines
Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein <t>nanoparticles,</t> inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.
Pfizer Biontech Covid 19 Lipid Np Mrna Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+mrna+based+vaccine/pmc10051709-79-8-8?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer-biontech covid-19 lipid np mrna vaccines - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mrna based (pfizer biontech moderna) vaccination  (BioNTech)
90
BioNTech mrna based (pfizer biontech moderna) vaccination
Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein <t>nanoparticles,</t> inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.
Mrna Based (Pfizer Biontech Moderna) Vaccination, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+mrna+based+vaccine/pm37072909-134-13-14?v=BioNTech
Average 90 stars, based on 1 article reviews
mrna based (pfizer biontech moderna) vaccination - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mrna-based nanolipid pfizer-biontech vaccine  (BioNTech)
90
BioNTech mrna-based nanolipid pfizer-biontech vaccine
Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein <t>nanoparticles,</t> inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.
Mrna Based Nanolipid Pfizer Biontech Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+mrna+based+vaccine/pm35995359-20-3-5?v=BioNTech
Average 90 stars, based on 1 article reviews
mrna-based nanolipid pfizer-biontech vaccine - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein nanoparticles, inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Emerging vaccine nanotechnology: From defense against infection to sniping cancer

doi: 10.1016/j.apsb.2021.12.021

Figure Lengend Snippet: Schematic illustration of emerging vaccine nanotechnology for infectious diseases prevention and cancer immunotherapy. Main types of nanovaccines include self-assembled protein nanoparticles, inorganic nanoparticles, polymeric and liposomal nanoparticles and biomimetic nanoparticles.

Article Snippet: The successful clinical application of the lipid nanoparticle-based Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines highlights promising future of nanotechnology in vaccine development.

Techniques:

(A) Self-assembled protein nanoparticles as HIV vaccines. Fully assembled protein nanoparticles display 20 copies of trimers. The protein nanovaccine induces specific IgG in mice and the immune response can be enhanced with army liposome formulation (ALF) as adjuvant. Reprinted with permission from Ref. . Copyright © 2019. Elsevier. (B) Design and application of high-density lipoprotein-mimicking nanodisc platform composed of lipids and peptides for co-delivery of Ag and CpG for as cancer vaccine. Subcutaneous injection of the nanovaccine induce DC maturation and elite robust Ag-specific CD8 + T cell responses, killing target cancer cells. This nanovaccine can be used in combination immunotherapy with immune checkpoint blockade. Reprinted with permission from Ref. . Copyright © 2017 Springer Nature.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Emerging vaccine nanotechnology: From defense against infection to sniping cancer

doi: 10.1016/j.apsb.2021.12.021

Figure Lengend Snippet: (A) Self-assembled protein nanoparticles as HIV vaccines. Fully assembled protein nanoparticles display 20 copies of trimers. The protein nanovaccine induces specific IgG in mice and the immune response can be enhanced with army liposome formulation (ALF) as adjuvant. Reprinted with permission from Ref. . Copyright © 2019. Elsevier. (B) Design and application of high-density lipoprotein-mimicking nanodisc platform composed of lipids and peptides for co-delivery of Ag and CpG for as cancer vaccine. Subcutaneous injection of the nanovaccine induce DC maturation and elite robust Ag-specific CD8 + T cell responses, killing target cancer cells. This nanovaccine can be used in combination immunotherapy with immune checkpoint blockade. Reprinted with permission from Ref. . Copyright © 2017 Springer Nature.

Article Snippet: The successful clinical application of the lipid nanoparticle-based Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines highlights promising future of nanotechnology in vaccine development.

Techniques: Injection

(A) Gold nanoparticle (GNP) decorated with high-mannoside-type oligosaccharides (P1@HM) and HIV-1-peptides-pulsed DC for HIV-specific T cell immunity. Reprinted with permission from Ref. © Copyright 2018. Elsevier. (B) Fabrication of PLGA nanoparticle loaded with tumor antigen, metformin and hollow gold nanospheres (TA-Met@MS) as tumor vaccines. Photothermal therapy (PTT) stimulate the nanoparticle to release antigen and drug for inducing immunogenicity. (C) TA-Met@MS treatment prolonged the survival of tumor bearing mice and suppressed tumor progression. Reprinted with permission from Ref. . Copyright © 2021 Elsevier.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Emerging vaccine nanotechnology: From defense against infection to sniping cancer

doi: 10.1016/j.apsb.2021.12.021

Figure Lengend Snippet: (A) Gold nanoparticle (GNP) decorated with high-mannoside-type oligosaccharides (P1@HM) and HIV-1-peptides-pulsed DC for HIV-specific T cell immunity. Reprinted with permission from Ref. © Copyright 2018. Elsevier. (B) Fabrication of PLGA nanoparticle loaded with tumor antigen, metformin and hollow gold nanospheres (TA-Met@MS) as tumor vaccines. Photothermal therapy (PTT) stimulate the nanoparticle to release antigen and drug for inducing immunogenicity. (C) TA-Met@MS treatment prolonged the survival of tumor bearing mice and suppressed tumor progression. Reprinted with permission from Ref. . Copyright © 2021 Elsevier.

Article Snippet: The successful clinical application of the lipid nanoparticle-based Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines highlights promising future of nanotechnology in vaccine development.

Techniques:

Typical clinical approved vaccines and candidates using nanotechnology for addressing infectious disease or cancer.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Emerging vaccine nanotechnology: From defense against infection to sniping cancer

doi: 10.1016/j.apsb.2021.12.021

Figure Lengend Snippet: Typical clinical approved vaccines and candidates using nanotechnology for addressing infectious disease or cancer.

Article Snippet: The successful clinical application of the lipid nanoparticle-based Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines highlights promising future of nanotechnology in vaccine development.

Techniques: Recombinant